Gene: RANBP6
Official Full Name: RAN binding protein 6provided by HGNC
Gene Summary: Predicted to enable nuclear import signal receptor activity and nuclear localization sequence binding activity. Predicted to be involved in protein import into nucleus. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27961 | RANBP6 Knockout cell line (HeLa) | Human | RANBP6 | 1:3~1:6 | Negative | Online Inquiry |
KO27962 | RANBP6 Knockout cell line (HCT 116) | Human | RANBP6 | 1:2~1:4 | Negative | Online Inquiry |
KO27963 | RANBP6 Knockout cell line (HEK293) | Human | RANBP6 | 1:3~1:6 | Negative | Online Inquiry |
KO27964 | RANBP6 Knockout cell line (A549) | Human | RANBP6 | 1:3~1:4 | Negative | Online Inquiry |
RANBP6 Gene Knockout Cell Lines are genetically engineered cellular models that lack the expression of the RANBP6 gene, a critical player in various cellular processes, including RNA metabolism and protein synthesis. By utilizing CRISPR-Cas9 technology, these knockout cell lines provide a precise tool for researchers to investigate the functional roles of RANBP6 in both physiological and pathological contexts.
The key functions of RANBP6 involve its interaction with multiple proteins and RNA molecules that are essential for maintaining cellular homeostasis. Through the ablation of this gene, researchers can elucidate the molecular mechanisms underlying RANBP6's contributions to cell proliferation, stress responses, and gene expression regulation. This understanding is vital for uncovering the impact of RANBP6 on diseases such as cancer and neurodegenerative disorders, thereby facilitating advancements in therapeutic strategies.
RANBP6 Gene Knockout Cell Lines hold significant scientific importance, with applications extending into various research areas, including developmental biology, cancer research, and molecular genetics. By providing a reliable model for the study of RANBP6, these cell lines enable scientists to explore the gene's role in cellular pathways and disease mechanisms, leading to novel insights and potential biomarkers for diagnosis and prognosis.
What sets our RANBP6 Gene Knockout Cell Lines apart from competing products is the rigorous validation process they undergo, ensuring high specificity and reproducibility. Researchers can trust that these cell lines will deliver consistent results, allowing them to focus more on their discoveries and less on troubleshooting experimental variations.
For clinicians and researchers invested in understanding the complexities of gene function and their implications in health and disease, these cell lines are invaluable assets. They provide an innovative platform for exploring therapeutic avenues and validating drug targets.
With a commitment to advancing science through innovative genetic tools, our company integrates cutting-edge technology and expert knowledge, providing the highest quality biological products to empower research and improve patient outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.